Celcuity, Inc. (CELC)
89.81
+1.57
(+1.78%)
USD |
NASDAQ |
Jun 11, 15:06
Celcuity Market Cap : 4.342B for June 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| June 10, 2026 | 4.266B |
| June 09, 2026 | 4.476B |
| June 08, 2026 | 4.227B |
| June 05, 2026 | 4.268B |
| June 04, 2026 | 4.471B |
| June 03, 2026 | 4.301B |
| June 02, 2026 | 4.420B |
| June 01, 2026 | 5.945B |
| May 29, 2026 | 6.424B |
| May 28, 2026 | 6.329B |
| May 27, 2026 | 6.533B |
| May 26, 2026 | 6.547B |
| May 22, 2026 | 6.741B |
| May 21, 2026 | 6.951B |
| May 20, 2026 | 6.844B |
| May 19, 2026 | 6.386B |
| May 18, 2026 | 6.446B |
| May 15, 2026 | 6.714B |
| May 14, 2026 | 6.570B |
| May 13, 2026 | 6.070B |
| May 12, 2026 | 6.080B |
| May 11, 2026 | 6.127B |
| May 08, 2026 | 6.335B |
| May 07, 2026 | 6.318B |
| May 06, 2026 | 6.740B |
| Date | Value |
|---|---|
| May 05, 2026 | 6.849B |
| May 04, 2026 | 7.008B |
| May 01, 2026 | 6.074B |
| April 30, 2026 | 5.866B |
| April 29, 2026 | 5.752B |
| April 28, 2026 | 5.804B |
| April 27, 2026 | 6.075B |
| April 24, 2026 | 5.850B |
| April 23, 2026 | 5.489B |
| April 22, 2026 | 5.917B |
| April 21, 2026 | 6.094B |
| April 20, 2026 | 5.805B |
| April 17, 2026 | 5.919B |
| April 16, 2026 | 6.054B |
| April 15, 2026 | 5.968B |
| April 14, 2026 | 5.841B |
| April 13, 2026 | 5.820B |
| April 10, 2026 | 5.662B |
| April 09, 2026 | 6.025B |
| April 08, 2026 | 5.652B |
| April 07, 2026 | 5.586B |
| April 06, 2026 | 5.521B |
| April 02, 2026 | 5.444B |
| April 01, 2026 | 5.459B |
| March 31, 2026 | 5.517B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Revolution Medicines, Inc. | 30.00B |
| Tango Therapeutics, Inc. | 4.208B |
| Kymera Therapeutics, Inc. | 6.786B |
| Cogent Biosciences, Inc. | 5.517B |
| Erasca, Inc. | 4.314B |
Market Cap Related Metrics
| PEG Ratio | -0.8016 |
| Price to Book Value | 81.12 |
| Price | 89.81 |
| Earnings Yield | -4.34% |
| PEGY Ratio | -0.8016 |